Home > Insider Trading > Filing (0001171843-14-005279)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
3116	Akorn Inc	AKRX	Pharmaceutical Preparations (2834)	720717400

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1365174	M Mark Silverberg	1925 West Field Court Suite 300 Lake Forest IL 60045	Exec Vp, Ops Global Qa&Techsrv	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-11-03	24,311	$44.27	183,109	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

On October 21, 2014, and pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2014, the reporting person filed a Form 4 reporting that 72,491 shares had been sold to pay exercise price and taxes due upon exercise of options. It was subsequently determined that, due to an administrative error, this was an insufficient number of shares necessary to cover the required withholding tax obligation. Accordingly, an additional 24,311 shares of stock were sold pursuant to the reporting person's Rule 10b5-1 trading plan.
Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $43.98 to $44.59 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at separate prices within the foregoing range.
Amount of Shares Beneficially Owned Following Reported Transaction includes 22,535 unvested shares subject to restricted stock awards and 160,574 shares owned outright.